Published in Health Econ on December 17, 1997
Cost effectiveness of seasonal intermittent preventive treatment using amodiaquine & artesunate or sulphadoxine-pyrimethamine in Ghanaian children. PLoS One (2010) 1.28
Resource allocation, social values and the QALY: a review of the debate and empirical evidence. Health Expect (2002) 1.20
Productivity costs in cost-effectiveness analysis: numerator or denominator: a further discussion. Health Econ (1997) 1.12
Short- and long-term outcomes following percutaneous cholecystostomy for acute cholecystitis in high-risk patients. Surg Endosc (2011) 1.07
Cost-effectiveness of eszopiclone for the treatment of adults with primary chronic insomnia. Sleep (2009) 0.88
Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies. Hum Vaccin Immunother (2013) 0.86
Understanding cost effectiveness: a detailed review. Br J Ophthalmol (2000) 0.80
Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA (1996) 14.23
Measurement of health state utilities for economic appraisal. J Health Econ (1986) 11.70
Health insurance and the demand for medical care: evidence from a randomized experiment. Am Econ Rev (1987) 10.58
The unreliability of individual physician "report cards" for assessing the costs and quality of care of a chronic disease. JAMA (1999) 9.97
A controlled trial of the effect of a prepaid group practice on use of services. N Engl J Med (1984) 9.61
The effects of excise taxes and regulations on cigarette smoking. J Health Econ (1991) 7.73
Five-hundred life-saving interventions and their cost-effectiveness. Risk Anal (1995) 7.45
The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA (1996) 6.80
Some interim results from a controlled trial of cost sharing in health insurance. N Engl J Med (1981) 6.76
Economic evaluation of neonatal intensive care of very-low-birth-weight infants. N Engl J Med (1983) 6.71
A utility maximization model for evaluation of health care programs. Health Serv Res (1972) 6.67
Starting insulin therapy in patients with type 2 diabetes: effectiveness, complications, and resource utilization. JAMA (1997) 6.00
Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics (1999) 4.86
Adjusting capitation rates using objective health measures and prior utilization. Health Care Financ Rev (1989) 4.64
Controlling health expenditures--the Canadian reality. N Engl J Med (1989) 4.36
Utilities and quality-adjusted life years. Int J Technol Assess Health Care (1989) 4.18
Multi-attribute health status classification systems. Health Utilities Index. Pharmacoeconomics (1995) 4.03
Utility approach to measuring health-related quality of life. J Chronic Dis (1987) 3.92
Randomized trial of a depression management program in high utilizers of medical care. Arch Fam Med (2000) 3.68
The utility of different health states as perceived by the general public. J Chronic Dis (1978) 3.65
Should we be measuring blood cholesterol levels in young adults? JAMA (1993) 3.57
The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med (2001) 3.57
Differences in the mix of patients among medical specialties and systems of care. Results from the medical outcomes study. JAMA (1992) 3.32
Taxation, regulation, and addiction: a demand function for cigarettes based on time-series evidence. J Health Econ (1993) 3.06
Application of multi-attribute utility theory to measure social preferences for health states. Oper Res (1983) 2.92
Do cigarette producers price-discriminate by state? An empirical analysis of local cigarette pricing and taxation. J Health Econ (1996) 2.70
Inappropriate use of hospitals in a randomized trial of health insurance plans. N Engl J Med (1986) 2.65
Smoking and alcohol abuse: a comparison of their economic consequences. N Engl J Med (1978) 2.62
The burden of illness of cancer: economic cost and quality of life. Annu Rev Public Health (2001) 2.59
The cost to health plans of poor glycemic control. Diabetes Care (1997) 2.55
Visual analog scales: do they have a role in the measurement of preferences for health states? Med Decis Making (2001) 2.49
Preventive care: do we practice what we preach? Am J Public Health (1987) 2.44
Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing. JAMA (1999) 2.33
The demand for dental care: evidence from a randomized trial in health insurance. J Am Dent Assoc (1985) 2.31
A political economic theory of the dental care market. Am J Public Health (1982) 2.23
Case mix, costs, and outcomes. Differences between faculty and community services in a university hospital. N Engl J Med (1984) 2.23
A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results. Osteoarthritis Cartilage (2002) 2.14
Cost-effectiveness of screening for carotid stenosis in asymptomatic persons. Ann Intern Med (1997) 1.93
Cost-effectiveness of systematic depression treatment for high utilizers of general medical care. Arch Gen Psychiatry (2001) 1.92
The demand for prescription drugs as a function of cost-sharing. Soc Sci Med (1985) 1.87
The new technology assessment. N Engl J Med (1990) 1.85
The pharmaceutical industry and health reform: lessons from Europe. Health Aff (Millwood) (1994) 1.81
Evaluation of the immunofluorescence procedure for detection of Giardia cysts and Cryptosporidium oocysts in water. Appl Environ Microbiol (1995) 1.77
Cost-effectiveness of androgen suppression therapies in advanced prostate cancer. J Natl Cancer Inst (2000) 1.75
Epidemiology of recurrent cerebral infarction: a medicare claims-based comparison of first and recurrent strokes on 2-year survival and cost. Stroke (1999) 1.74
Developing multiattribute health indexes. Med Care (1984) 1.73
Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis. Ann Intern Med (1999) 1.73
Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials. Ann Intern Med (1999) 1.72
Cost-effectiveness of antepartum prevention of Rh immunization. Clin Perinatol (1984) 1.71
Triglyceride concentration and coronary heart disease. BMJ (1994) 1.68
Screening for hypertension. Ann Intern Med (1990) 1.68
Developing and testing a multimedia presentation of a health-state description. Med Decis Making (1995) 1.68
A comprehensive multiattribute system for classifying the health status of survivors of childhood cancer. J Clin Oncol (1992) 1.66
Mortality and morbidity of 500- to 1,499-gram birth weight infants live-born to residents of a defined geographic region before and after neonatal intensive care. Pediatrics (1982) 1.63
The impact of cost sharing on emergency department use. N Engl J Med (1985) 1.61
Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on cost Effectiveness in Health and Medicine. Pharmacoeconomics (1997) 1.56
Measurement of quality of life in end-stage renal disease: the time trade-off approach. Clin Invest Med (1987) 1.53
Cost-effectiveness of automated external defibrillators on airlines. JAMA (2001) 1.52
Evaluation of neonatal-intensive-care program. N Engl J Med (1981) 1.52
Utilities for major stroke: results from a survey of preferences among persons at increased risk for stroke. Am Heart J (1998) 1.51
Health status and the use of outpatient mental health services. Am Psychol (1984) 1.51
Polymerase chain reaction for the diagnosis of HIV infection in adults. A meta-analysis with recommendations for clinical practice and study design. Ann Intern Med (1996) 1.50
The role of exercise testing in screening for coronary artery disease. Ann Intern Med (1989) 1.50
Complementary strand infectivity in phi X174 replicative form DNA. J Mol Biol (1967) 1.49
Sociodemographic factors and the use of outpatient mental health services. Med Care (1986) 1.47
Cost-effectiveness of clozapine for treatment-resistant schizophrenic patients. Hosp Community Psychiatry (1990) 1.46
Do attending or resident physician practice styles account for variations in hospital resource use? Med Care (1994) 1.45
Using cost-effectiveness analysis to target cholesterol reduction. Ann Intern Med (2000) 1.45
Physician payment reform: anesthesiology as a case study. Anesthesiology (1990) 1.43
Toward a utility theory foundation for health status index models. Health Serv Res (1976) 1.41
Inpatient costs of specific cerebrovascular events at five academic medical centers. Neurology (1996) 1.40
Assessing the cost-effectiveness of prevention. J Community Health (1983) 1.40
The demand for episodes of mental health services. J Health Econ (1988) 1.39
Physical disability among Canadians reporting musculoskeletal diseases. J Rheumatol (1992) 1.39
Computer-assisted medicine: economics of computing (part 1). Can Med Assoc J (1980) 1.39
Cost and health related quality of life consequences of multiple sclerosis. Mult Scler (2000) 1.35
Physician use in Ontario and the United States: The impact of socioeconomic status and health status. Am J Public Health (1996) 1.34
Symptom prevalence and odor-worry interaction near hazardous waste sites. Environ Health Perspect (1991) 1.34
Understanding racial variation in the use of carotid endarterectomy: the role of aversion to surgery. J Natl Med Assoc (1998) 1.33
Performing cost-effectiveness analysis by integrating randomized trial data with a comprehensive decision model: application to treatment of acute ischemic stroke. J Clin Epidemiol (1999) 1.27
An analysis of the cost effectiveness of the implantable defibrillator. Circulation (1990) 1.26
Ecological determinants in microbial colonization of the murine gastrointestinal tract: adherence of Torulopsis pintolopesii to epithelial surfaces. Infect Immun (1979) 1.25
Depression among high utilizers of medical care. J Gen Intern Med (1999) 1.24
Measurement of the validity of utility elicitations performed by computerized interview. Med Care (1997) 1.23
Effect of cost-sharing on the use of medical services by children: interim results from a randomized controlled trial. Pediatrics (1985) 1.23
Transit time of epithelial cells in the small intestines of germfree mice and ex-germfree mice associated with indigenous microorganisms. Appl Environ Microbiol (1981) 1.23
The comprehensive assessment of health status in survivors of childhood cancer: application to high-risk acute lymphoblastic leukaemia. Br J Cancer (1993) 1.20
Costing medical care: using Medicare administrative data. Med Care (1994) 1.20
The effect of assessment method and respondent population on utilities elicited for Gaucher disease. Qual Life Res (1997) 1.20
Reliability of the Health Utilities Index--Mark III used in the 1991 cycle 6 Canadian General Social Survey Health Questionnaire. Qual Life Res (1995) 1.19
Prepaid group practice effects on the utilization of medical services and health outcomes for children: results from a controlled trial. Pediatrics (1989) 1.19
Hypotheses to explain the higher symptom rates observed around hazardous waste sites. Environ Health Perspect (1991) 1.18
Health care CBA/CEA: an update on the growth and composition of the literature. Med Care (1993) 1.17
Health care CBA and CEA from 1991 to 1996: an updated bibliography. Med Care (1998) 1.17
The Stroke Prevention Policy Model: linking evidence and clinical decisions. Ann Intern Med (1997) 1.16
The external costs of a sedentary life-style. Am J Public Health (1989) 1.16
Measuring the wellbeing of family caregivers using the time trade-off technique. J Clin Epidemiol (1988) 1.14
Comparison of analytic models for estimating the effect of clinical factors on the cost of coronary artery bypass graft surgery. J Clin Epidemiol (1993) 1.14
Managed care pharmacy, socioeconomic assessments and drug adoption decisions. Soc Sci Med (1997) 1.13